Dhanuka Agritech Limited — Investor Meet, 12-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Dhanuka Agritech's Q3 FY26 saw revenue decline to ₹409.92 Cr (vs ₹445.27 Cr YoY), with EBITDA at ₹58.66 Cr and PAT at ₹40 Cr, primarily due to weak agrochemical demand from weather issues and low crop prices. However, Q4 has started well. The company anticipates resolving biostimulant regulatory issues by Q1 FY27, with 3 key products relaunching. Management expects FY26 to be a flattish year but projects double-digit CAGR growth in the medium term, driven by new product launches and Dahej plant utilization. Discussions are underway for multinational tie-ups at Dahej. Management expresses confidence in future performance, stating the "bad phase is over."